Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilm-forming activity

References

1. Agnello M., Wong-Beringer A. 2012; Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa. PLoS ONE 7:e42973 [View Article][PubMed]
   [Google Scholar]
2. Bodilis J., Ghysels B., Osayande J., Matthijs S., Pirnay J. P., Denayer S., De Vos D., Cornelis P. 2009; Distribution and evolution of ferripyoverdine receptors in Pseudomonas aeruginosa. Environ Microbiol 11:2123–2135 [View Article][PubMed]
   [Google Scholar]
3. Cholley P., Thouverez M., Hocquet D., van der Mee-Marquet N., Talon D., Bertrand X. 2011; Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J Clin Microbiol 49:2578–2583 [View Article][PubMed]
   [Google Scholar]
4. CLSI (2011). Performance Standards for Antimicrobial Susceptibility Testing, 21st Informational Supplement M100–S21. Wayne, PA: Clinical and Laboratory Standards Institute
5. Cornelis P., Hohnadel D., Meyer J. M. 1989; Evidence for different pyoverdine‐mediated iron uptake systems among Pseudomonas aeruginosa strains.. Infect Immun 57:3491–3497 [View Article][PubMed]
   [Google Scholar]
6. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C. G. 2004; Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.. J Clin Microbiol 42:5644–5649 [View Article][PubMed]
   [Google Scholar]
7. De Vos D., De Chial M., Cochez C., Jansen S., Tümmler B., Meyer J.M., Cornelis P. 2001; Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine‐negative mutations. Arch Microbiol 175:384–388 [View Article][PubMed]
   [Google Scholar]
8. García-Castillo M., Del Campo R., Morosini M. I., Riera E., Cabot G., Willems R., van Mansfeld R., Oliver A., Cantón R. 2011; Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J Clin Microbiol 49:2905–2910 [View Article][PubMed]
   [Google Scholar]
9. Giske C. G., Libisch B., Colinon C., Scoulica E., Pagani L., Füzi M., Kronvall G., Rossolini G. M. 2006; Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. J Clin Microbiol 44:4309–4315 [View Article][PubMed]
   [Google Scholar]
10. Goodman A. L., Lory S. 2004; Analysis of regulatory networks in Pseudomonas aeruginosa by genomewide transcriptional profiling. Curr Opin Microbiol 7:39–44 [View Article][PubMed]
    [Google Scholar]
11. Handfield M., Lehoux D. E., Sanschagrin F., Mahan M.J., Woods D.E., Levesque R.C. 2000; In vivo‐induced genes in Pseudomonas aeruginosa. Infect Immun 68:2359–2362 [View Article][PubMed]
    [Google Scholar]
12. Kaszab E., Szoboszlay S., Dobolyi C., Háhn J., Pék N., Kriszt B. 2011; Antibiotic resistance profiles and virulence markers of Pseudomonas aeruginosa strains isolated from composts. Bioresour Technol 102:1543–1548 [View Article][PubMed]
    [Google Scholar]
13. Kitao T., Tada T., Tanaka M., Narahara K., Shimojima M., Shimada K., Miyoshi-Akiyama T., Kirikae T. 2012; Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6′)-Iae in Japan. Int J Antimicrob Agents 39:518–521 [View Article][PubMed]
    [Google Scholar]
14. Kulasekara B. R., Kulasekara H. D., Wolfgang M. C., Stevens L., Frank D. W., Lory S. 2006; Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa. J Bacteriol 188:4037–4050 [View Article][PubMed]
    [Google Scholar]
15. Lee J. Y., Ko K. S. 2012; OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea. Int J Antimicrob Agents 40:168–172 [View Article][PubMed]
    [Google Scholar]
16. Lin H. H., Huang S. P., Teng H. C., Ji D. D., Chen Y. S., Chen Y. L. 2006; Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice. J Clin Microbiol 44:4596–4597 [View Article][PubMed]
    [Google Scholar]
17. Maatallah M., Cheriaa J., Backhrouf A., Iversen A., Grundmann H., Do T., Lanotte P., Mastouri M., Elghmati M. S. et al. 2011; Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS ONE 6:e25617 [View Article][PubMed]
    [Google Scholar]
18. Merritt J. H., Kadouri D. E., O'Toole G. A. 2005; Growing and analyzing static biofilms. In Current Protocols in Microbiology pp. 1B.1.1–1B.1.17 Edited by Coico R., Kowalik T., Quarles J., Stevenson B., Taylor R. Hoboken, NJ: Wiley;
    [Google Scholar]
19. Meyer J. M., Neely A., Stintzi A., Georges C., Holder I. A. 1996; Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun 64:518–523 [View Article][PubMed]
    [Google Scholar]
20. Meyer J. M., Stintzi A., De Vos D., Cornelis P., Tappe R., Taraz K., Budzikiewicz H. 1997; Use of siderophores to type pseudomonads: the three Pseudomonas aeruginosa pyoverdine systems. Microbiology 143:35–43 [View Article][PubMed]
    [Google Scholar]
21. Murray T. S., Kazmierczak B. I. 2006; FlhF is required for swimming and swarming in Pseudomonas aeruginosa. J Bacteriol 188:6995–7004 [View Article][PubMed]
    [Google Scholar]
22. Nemec A., Krizova L., Maixnerova M., Musilek M. 2010; Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Res Microbiol 161:234–242 [View Article][PubMed]
    [Google Scholar]
23. Poole K. 2011; Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65 [View Article][PubMed]
    [Google Scholar]
24. Seok Y., Bae I. K., Jeong S. H., Kim S. H., Lee H., Lee K. 2011; Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea. J Antimicrob Chemother 66:2791–2796 [View Article][PubMed]
    [Google Scholar]
25. Shaver C. M., Hauser A. R. 2004; Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 72:6969–6977 [View Article][PubMed]
    [Google Scholar]
26. Shigemoto N., Kuwahara R., Kayama S., Shimizu W., Onodera M., Yokozaki M., Hisatsune J., Kato F., Ohge H., Sugai M. 2012; Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying bla_IMP-6.. Diagn Microbiol Infect Dis 72:109–112 [View Article][PubMed]
    [Google Scholar]
27. Struelens M. J., Rost F., Deplano A., Maas A., Schwam V., Serruys E., Cremer M. 1993; Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am J Med 95:489–498 [View Article][PubMed]
    [Google Scholar]
28. Szmolka A., Cramer N., Nagy B. 2012; Comparative genomic analysis of bovine, environmental, and human strains of Pseudomonas aeruginosa. FEMS Microbiol Lett 335:113–122 [View Article][PubMed]
    [Google Scholar]
29. Tingpej P., Smith L., Rose B., Zhu H., Conibear T., Al Nassafi K., Manos J., Elkins M., Bye P. et al. 2007; Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45:1697–1704 [View Article][PubMed]
    [Google Scholar]
30. Twining S. S., Kirschner S. E., Mahnke L. A., Frank D. W. 1993; Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci 34:2699–2712[PubMed]
    [Google Scholar]
31. Wiehlmann L., Wagner G., Cramer N., Siebert B., Gudowius P., Morales G., Köhler T., van Delden C., Weinel C. et al. 2007; Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 104:8101–8106 [View Article][PubMed]
    [Google Scholar]
32. Yan J. J., Hsueh P. R., Ko W. C., Luh K. T., Tsai S. H., Wu H. M., Wu J. J. 2001; Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 45:2224–2228 [View Article][PubMed]
    [Google Scholar]
33. Yano H., Kuga A., Okamoto R., Kitasato H., Kobayashi T., Inoue M. 2001; Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 45:1343–1348 [View Article][PubMed]
    [Google Scholar]
34. Yoo J. S., Yang J. W., Kim H. M., Byeon J., Kim H. S., Yoo J. I., Chung G. T., Lee Y. S. 2012; Dissemination of genetically related IMP-6-producing multidrug-resistant Pseudomonas aeruginosa ST235 in South Korea. Int J Antimicrob Agents 39:300–304 [View Article][PubMed]
    [Google Scholar]
35. Zhu H., Thuruthyil S. J., Willcox M. D. 2001; Production of N-acyl homoserine lactones by gram-negative bacteria isolated from contact lens wearers. Clin Experiment Ophthalmol 29:150–152 [View Article][PubMed]
    [Google Scholar]
36. Zhu H., Thuruthyil S. J., Willcox M. D. 2002; Determination of quorum-sensing signal molecules and virulence factors of Pseudomonas aeruginosa isolates from contact lens-induced microbial keratitis. J Med Microbiol 51:1063–1070[PubMed]
    [Google Scholar]